| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |